ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer
SAN CLEMENTE, CA / ACCESSWIRE / October 30, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, announced today the appointment of Thomas Stankovich as Chief Financial Officer (CFO) effective immediately. "We are happy to have Tom join our senior leadership team as CFO," commented Bart Bandy, President and Chief Executive Officer of...
Read more









